CAAS Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-454,095
Closed -$18.3M 1247
2020
Q4
$18.3M Hold
454,095
0.17% 127
2020
Q3
$25.2M Buy
+454,095
New +$24M 0.59% 36

Other funds holding GDRX

CAAS Capital Management's GDRX Position: Q1 2021 in Review

CAAS Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 454,095 shares — an estimated $18.3M sold.

CAAS Capital Management first reported a position in GDRX in Q3 2020 and held it in 2 quarters. The position peaked at $25.2M in Q3 2020. 205 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.

  • CAAS Capital Management reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 454,095 GoodRx Holdings shares in Q1 2021, an estimated $18.3M.
  • CAAS Capital Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 2 quarters.
  • CAAS Capital Management's GoodRx Holdings position peaked at $25.2M in Q3 2020.
  • 205 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.